Name: | Description: | Size: | Format: | |
---|---|---|---|---|
4.07 MB | Adobe PDF |
Advisor(s)
Abstract(s)
The composition of seaweeds is complex, with vitamins, phenolic compounds, minerals,
and polysaccharides being some of the factions comprising their structure. The main polysaccharide
in brown seaweeds is fucoidan, and several biological activities have been associated with its structure.
Chitosan is another marine biopolymer that is very popular in the biomedical field, owing to its
suitable features for formulating drug delivery systems and, particularly, particulate systems. In this
work, the ability of fucoidan to produce nanoparticles was evaluated, testing different amounts of
a polymer and using chitosan as a counterion. Nanoparticles of 200–300 nm were obtained when
fucoidan prevailed in the formulation, which also resulted in negatively charged nanoparticles.
Adjusting the pH of the reaction media to 4 did not affect the physicochemical characteristics of the
nanoparticles. The IC50 of fucoidan was determined, in both HCT−116 and A549 cells, to be around
160 µg/mL, whereas it raised to 675–100 µg/mL when nanoparticles (fucoidan/chitosan = 2/1, w/w)
were tested. These marine materials (fucoidan and chitosan) provided features suitable to formulate
polymeric nanoparticles to use in biomedical applications.
Description
Keywords
Antioxidant Cell proliferation Chitosan Fucoidan Fucus vesiculosus Nanoparticles Rheology
Citation
Marine Drugs 21 (2): 115 (2023)
Publisher
MDPI